Clinical trial
A Prospective Study of Tolerance Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration
NCT04362449 is registered in ClinicalTrials.gov with Imperial College Healthcare NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of Tolerance Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration
- Lead sponsor
- Imperial College Healthcare NHS Trust
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 2, 2019
- Completion date
- February 2, 2023
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gallbladder cancer